Modification of a sonographic enthesitis score to differentiate between psoriatic arthritis and young healthy volunteers by Wervers, K. (Kim) et al.
Full Terms & Conditions of access and use can be found at
http://www.tandfonline.com/action/journalInformation?journalCode=irhe20
Download by: [Erasmus University] Date: 09 January 2018, At: 01:57
Scandinavian Journal of Rheumatology
ISSN: 0300-9742 (Print) 1502-7732 (Online) Journal homepage: http://www.tandfonline.com/loi/irhe20
Modification of a sonographic enthesitis score to
differentiate between psoriatic arthritis and young
healthy volunteers
K Wervers, M Vis, N Rasappu, M van der Ven, I Tchetverikov, MR Kok, AH
Gerards, JMW Hazes & JJ Luime
To cite this article: K Wervers, M Vis, N Rasappu, M van der Ven, I Tchetverikov, MR Kok,
AH Gerards, JMW Hazes & JJ Luime (2018): Modification of a sonographic enthesitis score to
differentiate between psoriatic arthritis and young healthy volunteers, Scandinavian Journal of
Rheumatology, DOI: 10.1080/03009742.2017.1393695
To link to this article:  https://doi.org/10.1080/03009742.2017.1393695
© 2017 The Author(s). Published by Informa
UK Limited, trading as Taylor & Francis
Group.
View supplementary material 
Published online: 02 Jan 2018. Submit your article to this journal 
Article views: 42 View related articles 
View Crossmark data
Modiﬁcation of a sonographic enthesitis score to differentiate between
psoriatic arthritis and young healthy volunteers
K Wervers1, M Vis1, N Rasappu1, M van der Ven1, I Tchetverikov2, MR Kok3, AH Gerards4, JMW Hazes1, JJ Luime1
1Department of Rheumatology, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands
2Department of Rheumatology, Albert Schweitzer Hospital, Dordrecht, The Netherlands
3Department of Rheumatology, Maasstad Hospital, Rotterdam, The Netherlands
4Department of Rheumatology, Vlietland Hospital, Schiedam, The Netherlands
Objectives: We aimed to describe sonographic structural and inﬂammatory changes in entheses of patients with
recently diagnosed psoriatic arthritis (PsA), patients with established PsA, and young healthy volunteers, and to
investigate whether the MAdrid Sonographic Enthesitis Index (MASEI) enables us to distinguish these groups in an
extreme comparison.
Method: New and established PsA patients and healthy volunteers (aged 20–30 years) were recruited. The triceps,
quadriceps, patellar, Achilles and elbow extensor tendon insertion, and plantar fascia entheses were investigated
sonographically for structural changes, erosions, calciﬁcations, increased thickness, bursitis, and power Doppler (PD)
signal according to the MASEI.
Results: The study included 25 new and 25 established PsA patients, and 25 healthy volunteers. Increased thickness
and PD signal in knee entheses were common for patients and healthy volunteers, while changes at other locations
predominantly occurred in patients only. PD was recoded (1, one spot; 1.5, two or three spots; 2, conﬂuent signal;
3, severe conﬂuent signal) and thickness of knee entheses excluded. This resulted in different modiﬁed MASEI scores
between PsA patients and young healthy controls: median (interquartile range) modiﬁed MASEI of 13 (10–22.5) in new
PsA, 13.5 (9.5–18) in established PsA, and 3 (1–8.5) in healthy volunteers (p = 0.002).
Conclusions: Structural ultrasound changes and PD in entheses are common in both new and established PsA and healthy
controls. MASEI score did not differentiate PsA patients from young healthy volunteers. After recoding of PD severity
and excluding thickness of knee entheses, marked differences between PsA patients and healthy controls were observed.
Enthesitis is an entry criterion of the ClASsiﬁcation criteria
for Psoriatic ARthritis (CASPAR) criteria (1). It is an
inﬂammation of tendon, ligament, or joint capsule inser-
tion, with an estimated prevalence of 25–78% (2). The
presentation is similar to other tendon complaints that are
quite common in the healthy population (3). Therefore,
general practitioners, dermatologists, and rheumatologists
do not always recognize the presence of enthesitis or its
association with psoriatic arthritis (PsA) (2).
In research, enthesitis is scored by counting the number
of tender entheses. Tenderness does not occur in inﬂam-
matory enthesiopathy alone (4, 5). Other means may help
to differentiate inﬂammatory from non-inﬂammatory
entheseal tenderness. Ultrasound can be used to investigate
multiple superﬁcially located entheses. Abnormalities can
be quantiﬁed with a combined score, for example the
MAdrid Sonographic Enthesitis Index (MASEI) (6).
The main objective of this cross-sectional study was to
investigate the frequency of ultrasound changes at the
entheses of patients with recently diagnosed PsA, patients
with established PsA, and young healthy volunteers (aged
20–30 years). In this extreme comparison, we aimed to
describe sonographic signs of enthesitis in clearly diseased
and clearly non-diseased entheses. The secondary objec-
tive was to investigate whether an enthesitis score (using
the MASEI) was able to distinguish between the three
groups. We chose a control group of young healthy volun-
teers because their tendons have matured but have had
limited exposure to the other causes of enthesiopathy.
Method
Patients and setting
Three groups of participants were investigated: new PsA
patients, established PsA patients and healthy volunteers
Kim Wervers, Department of Rheumatology (NA-607), Erasmus MC,
University Medical Centre, PO Box 2040, 3000 CA Rotterdam, The
Netherlands.
E-mail: k.wervers@erasmusmc.nl
Accepted 14 October 2017
Scand J Rheumatol 2017;00:1–4 1
© 2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/
licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not
altered, transformed, or built upon in any way.
DOI: https://doi.org/10.1080/03009742.2017.1393695 www.scandjrheumatol.dk
D
ow
nl
oa
de
d 
by
 [E
ras
mu
s U
niv
ers
ity
] a
t 0
1:5
7 0
9 J
an
ua
ry
 20
18
 
(aged 20–30 years). Consecutive newly diagnosed and
established patients were included in hospitals in the
south-west of the Netherlands. Established disease was
deﬁned as having been diagnosed with PsA for at least
2 years. Those patients were included irrespective of
disease activity. To reduce the impact of age on ultra-
sound readings and clinical evaluation, an age limit of
55 years was set in the established PsA group. Healthy
20–30-year-old volunteers were recruited via advertise-
ment at the medical faculty and by word of mouth.
Exclusion criteria for healthy volunteers were familiar
hypercholesterolaemia, diabetes mellitus, and having
any rheumatological disease. Participants were recruited
from May 2015 to January 2016. Written informed con-
sent was obtained from all participants according to the
Declaration of Helsinki. The study was approved by the
local medical research ethics committee of Erasmus MC,
University Medical Center Rotterdam, the Netherlands
(MEC-2012-549).
Data collection
Ultrasound examination of the entheses was performed
by a trained sonographer (KW) who was blinded to the
clinical information. An Esaote MyLab60 with the Probe
LA-435 (6–18 MHz; Doppler frequency of 8.3 MHz,
pulse repetition frequency of 750 Hz, and a wall ﬁlter of
3) and Probe LA-523 (4–13 MHz; 6.3 MHz, 750 Hz,
and a wall ﬁlter of 4) was used. A colour gain was set at
the disappearance of colour noise in the bone underneath
the enthesis. The six MASEI locations and the common
extensor insertion at the lateral epicondyle of the elbow
[increased thickness cut-off 4.2 mm (7)] were assessed
bilaterally. Each ultrasound location was scored for cal-
ciﬁcations, erosions, increased thickness, structure,
power Doppler (PD) signal, and bursitis, in accordance
with the MASEI (6).
Positioning of patients followed the recommendations
of the MASEI developers, but with the knee ﬂexed at
approximately 30° instead of 70° to improve PD signal
detection (8). The lateral epicondyle was examined in
90° elbow ﬂexion. PD was scored with a semi-quantita-
tive scoring system similar to the method used in arthri-
tis (9): 0, absent; 1, one colour spot; 1.5, two colour
spots; 2, conﬂuent signal; and 3, severe signal (Supple-
mentary Figure S1). Interrater agreement of rescoring
was 93% and the weighted Cohen’s kappa with linear
weights was 0.92.
Statistical methods
Simple descriptive techniques ﬁtting the distribution
were used to describe the study results and determine
whether ultrasound data differed in the three groups, in
STATA 14.0.
Results
Participants
In total, 75 participants were evaluated: 25 new PsA and
25 established PsA patients, and 25 young healthy
volunteers. Median disease duration was 2.9 weeks in
new PsA and 8.0 years in established PsA (Table 1).
Median symptom duration of musculoskeletal com-
plaints as reported by the new patients was 1.2 years
[interquartile range (IQR) 0.6–3.1 years].
Structural ultrasound ﬁndings
Calciﬁcations were seen in all locations of entheses in
patients, with the highest prevalence at the lateral epi-
condyle (entheses of new 56% vs established 28%),
quadriceps tendon (68% vs 50%), and Achilles tendon
(70% vs 56%) (Table 2 and Supplementary Table S1). In
entheses of healthy volunteers, calciﬁcations were seen
far less frequently and they mainly occurred in the
quadriceps tendon (30%). Increased thickness was seen
at all locations in patient entheses, with the highest
Table 1. Characteristics of the participants in the three groups.
New PsA
(n = 25)
Established PsA
(n = 25)
Healthy volunteers
(n = 25)
Male, n (%) 13 (52) 13 (52) 12 (48)
Age (years), median (range) 52 (30–72) 44 (26–53) 22 (20–26)
Time since PsA diagnosis, median (IQR) 2.9 (0.7–5.3) weeks 8.0 (5.0–11.0) years
Medication, n (%)
DMARDs 4 (16)* 17 (68)
Biologicals 0 (0) 5 (20)
Both DMARDs and biologicals 0 (0) 3 (12)
LEI, median (IQR) 1 (0–1) 1 (0–2) 0 (0–0)
MASES, median (IQR) 0 (0–4) 1 (1–3) 0 (0–0)
PsA, psoriatic arthritis; IQR, interquartile range; DMARD, disease-modifying anti-rheumatic drug; LEI, Leeds Enthesitis Index (range
0–6); MASES, Maastricht Ankylosing Spondylitis Enthesitis Score (range 0–13).
*All DMARD use duration < 1 week.
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prevalence at the lateral epicondyle (entheses of new
80% vs established 74%) and at the knee entheses (pre-
valence range 52–82%). In healthy volunteers, only knee
entheses had an increased thickness (range 50–70%).
Inﬂammatory ultrasound ﬁndings
The majority of patients and half of the healthy volun-
teers had a PD signal present in at least one enthesis
(Table 3). A PD score of 2 or more in at least one
enthesis was present in 52% of new and 44% of estab-
lished PsA patients and in 28% of healthy volunteers.
The lateral epicondyle and the quadriceps tendon were
affected in one-third of the entheses in patients
(Table 2). In healthy volunteers, one-third of the quad-
riceps entheses and distal patellar entheses showed a PD
signal.
MASEI
The median MASEI score with the lateral epicondyle
added was 18 (IQR 15–31) in new with PsA, 22 (IQR
15–27) in established PsA, and 10 (IQR 5–15) in healthy
volunteers (p = 0.002). As described before, the main
contributors to the MASEI scores in healthy volunteers
were increased thickness and PD signal in knee entheses.
After we excluded knee entheseal thickness and used the
new PD scores, the IQRs were no longer overlapping.
The scores of the modiﬁed MASEI were 13 (IQR
10–22.5), 13.5 (IQR 9.5–18), and 3 (IQR 1–8.5,
p = 0.002) (Table 3).
Discussion
Sonographic changes in the entheses were observed in
young, healthy volunteers, patients with recently diag-
nosed PsA, and patients with established PsA. Increased
thickness and a subtle positive PD signal in knee
entheses were common in healthy volunteers and
patients, while abnormalities at other locations predomi-
nantly occurred in patients. After we excluded patellar
tendon enthesis thickness and applied a new method of
scoring PD, the modiﬁed MASEI was able to distinguish
between PsA patients and healthy controls. Furthermore,
Table 2. MAdrid Sonographic Enthesitis Index (MASEI) score per component per enthesis location (n = 50 per group).
Structure Thickness Erosion Calciﬁcation* PD signal Bursitis
A B C A B C A B C A B C A B C A B C
Lateral epicondyle tendon 4 80 74 20 2 56 28 8 36 34
Triceps tendon 2 2 16 14 2 6 4 16 22 2 10
Quadriceps tendon 2 8 2 66 56 50 2 68 50 30 28 30 34
Proximal patella tendon 4 52 60 58 2 22 12 6 8 12 2
Distal patella tendon 12 82 74 70 2 18 16 16 14 30
Achilles tendon 8 26 4 8 4 70 56 8 8 10 2 8 6
Plantar fascia 24 28 4 16 2 6
Data are shown as the number of abnormalities (%) per group.
PD, power Doppler; A, new psoriatic arthritis patients; B, established psoriatic arthritis patients; C, healthy volunteers.
*Calciﬁcation is expressed as the number of tendons with a score > 0.
Table 3. Outcome of the MAdrid Sonographic Enthesitis Index (MASEI) scoring system and different adjustments to the MASEI
scoring system in the three participant groups.
New PsA
(n = 25)
Established PsA
(n = 25)
Healthy volunteers
(n = 25)
Ultrasound examination
MASEI* 15 (11–25) 16 (11–26) 10 (5–13)
PD
PD in any enthesis 76% 96% 56%
PD ≥ 2 in any enthesis 52% 44% 28%
≥ 3 entheses with PD 20% 32% 24%
Amendments (stepwise)
+ Lateral epicondyle 18 (15–31) 22 (15–27) 10 (5–15)
– Quadriceps thickness 13 (11–28) 17 (12–23) 5 (2–12)
Amending PD score† 13 (10–22.5) 13.5 (9.5–18) 3 (1–8.5)
Data are shown as median (interquartile range) or percentage of participants.
PsA, psoriatic arthritis; PD, power Doppler signal.
*Range 0–136. †Using new scoring system to award points for PD: 1a was given 1 point and 1b 1.5 points.
Sonographic enthesitis in PsA 3
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we showed that ultrasound abnormalities are already
very common in early PsA.
The extreme contrast we expected between young
healthy volunteers and PsA was not reﬂected in the
MASEI score. We chose to compare PsA patients and
clearly non-diseased young subjects, expecting a big
contrast owing to differences in disease status and age.
Tendon thickness reference values explained part of the
overlap, especially in the case of the knee entheses. The
reference values originate from an ultrasound study of
human cadaveric limbs aged 67–87 years (10) and prob-
ably underestimate enthesis thickness. Small spots of PD
signal in healthy volunteers further diminished the
expected extreme contrast. Our ﬁndings seem to suggest
that a single spot of PD is not of value in identifying
active entheseal inﬂammation and that at least a conﬂu-
ent signal is necessary. Furthermore, the patellar tendon
is susceptible to showing hypervascularity after acute
physical stress. A study performing PD examination on
runners showed hypervascularity in the patellar tendon
directly after a marathon (11).
Our results raise questions and challenges for the
future. First, our controls were not age matched. There-
fore, the differences between controls and patients can-
not solely be ascribed to entheseal inﬂammation due to
PsA. The effect of ageing is likely to play a role as well,
which is also reﬂected in higher scores in the slightly
older new PsA group. The effect of factors such as
obesity, physical exercise, age, and gender could not
be analysed, as the subgroups would be too small to
analyse. Secondly, compared to other studies in early
PsA, we found slightly higher scores on PD, possibly
due to differences in study design and the machines used
(12, 13).
Conclusion
Ultrasound structural changes and inﬂammation in the
enthesis were common in both new and established PsA
patients, and in the knees of healthy young adults, using
the MASEI score. Excluding knee entheses thickness
and reﬁnement of PD signal scores provided
discrimination of PsA from healthy young volunteers
in terms of enthesis pathology.
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